GlassScriptPhysician profile
Scott M Boswell
NPI 1801093224
$5,180.26
in general payments reported to CMS, 2019-2025
12 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.20 · 2020: $30.56 · 2021: $40.67 · 2022: $2,223 · 2023: $1,833 · 2024: $834 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,306 · Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,305.82 |
| Food and Beverage | $509.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $4,583.01 | 2022-2025 | Excelsiusgps Robotic Navigation System, Senza |
| Nevro Corp. | $157.22 | 2022-2024 | Senza |
| Microtransponder, INC. | $97.16 | 2025 | |
| Abbott Laboratories | $82.97 | 2022-2023 | Proclaim |
| Medtronic, INC. | $64.31 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Abbvie INC. | $48.72 | 2023 | Botox |
| Medtronic USA, INC. | $43.91 | 2019-2020 | |
| Paradigm Spine, LLC | $39.07 | 2019 | |
| Allergan, INC. | $17.78 | 2020 | |
| Galderma Laboratories, L.P. | $16.15 | 2024 | |
| Depuy Synthes Sales INC. | $15.89 | 2022 | |
| Boston Scientific Corporation | $14.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Boswell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.